Article
Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
European heart journal - 21 Sept 2022
Perea-Gil Isaac, Seeger Timon, Bruyneel Arne A N, Termglinchan Vittavat, Monte Emma, Lim Esther W, Vadgama Nirmal, Furihata Takaaki, Gavidia Alexandra A, Arthur Ataam Jennifer, Bharucha Nike, Martinez-Amador Noel, Ameen Mohamed, Nair Pooja, Serrano Ricardo, Kaur Balpreet, Feyen Dries A M, Diecke Sebastian, Snyder Michael P, Metallo Christian M, Mercola Mark, Karakikes Ioannis
Abstract excerpt
AIMS: Genetic dilated cardiomyopathy (DCM) is a leading cause of heart failure. Despite significant progress in understanding the genetic aetiologies of DCM, the molecular mechanisms underlying the pathogenesis of familial DCM remain unknown, translating to a lack of disease-specific therapies. The discovery of novel targets for the treatment of DCM was sought using phenotypic sceening assays in induced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
